263 related articles for article (PubMed ID: 28645102)
1. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
[TBL] [Abstract][Full Text] [Related]
4. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
5. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
Wang SJ; Earle C; Wong G; Bourguignon LY
Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
[TBL] [Abstract][Full Text] [Related]
6. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.
Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW
BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427
[TBL] [Abstract][Full Text] [Related]
7. Effect of p63 expression on survival in oral squamous cell carcinoma.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
[TBL] [Abstract][Full Text] [Related]
9. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
10. p63 and E-cadherin Expression in Canine Oral Squamous Cell Carcinoma.
Mestrinho LA; Pissarra H; Faísca PB; Bragança M; Peleteiro MC; Niza MM
Vet Pathol; 2015 Jul; 52(4):614-20. PubMed ID: 25248518
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.
Sawant S; Gokulan R; Dongre H; Vaidya M; Chaukar D; Prabhash K; Ingle A; Joshi S; Dange P; Joshi S; Singh AK; Makani V; Sharma S; Jeyaram A; Kane S; D'Cruz A
Clin Oral Investig; 2016 Jan; 20(1):43-56. PubMed ID: 25914047
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
13. Prognostic markers in stage I oral cavity squamous cell carcinoma.
Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
[TBL] [Abstract][Full Text] [Related]
14. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
15. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.
Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
19. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]